Type 2 Diabetes Study

Now Enrolling in Albuquerque, Austin, Banning, Providence, and Syracuse

Now Enrolling

About this research study

While diet and exercise can help manage the symptoms of type 2 diabetes (T2D), there is no cure. People with T2D either resist the effects of insulin, or their bodies don’t produce enough of the hormone to maintain normal levels of glucose. Velocity is now conducting a clinical trial for an investigational diabetes medication.

Eligible participants...

  • Must be age 18 or older
  • Must have a diagnosis of type 2 diabetes mellitus for at least 180 days
  • Must be on a stable daily dose of metformin with or without an SGLT2 inhibitor for at least 90 days
  • Must have a BMI of 25 kg/m2 or greater
  • Will receive compensation for study-related time

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Albuquerque, New Mexico • Velocity Clinical Research

3901 Carlisle Blvd NE, Albuquerque, NM 87107
Phone: (505) 243-1627

Austin, Texas • Velocity Clinical Research

12515-2 Research Blvd, Suite 225, Austin, TX 78759
Phone: (512) 506-8287

San Bernardino, California • Velocity Clinical Research

650 E. Hospitality Lane, Suite 200, San Bernardino, CA 92408
Phone: (951) 755-0222

Providence (East Greenwich), Rhode Island • Velocity Clinical Research

1598 South County Trail, Suite 204, East Greenwich, RI 02818
Phone: (401) 739-9350

Syracuse, New York • Velocity Clinical Research

5000 Brittonfield Parkway, Suite B105, East Syracuse, NY 13057
Phone: (315) 760-5905

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy